UK markets close in 2 hours 54 minutes

Stryker Corporation (0R2S.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
243.95-2.89 (-1.17%)
As of 3:33PM GMT. Market open.
Sign in to post a message.
  • i
    My new Stryker hip is doing well after a short period. I was happy tp controbute to your earnings.
  • B
    Bill mddb
    Taking a beating going into earnings. Stryker has a trail of better than expected earnings. Even a nice report may get washed over by a negative market. But the trend is your friend if you are long SYK. We'll see some numbers soon.
  • P
    Love this company, bought in around 170 a few months back. They have a strong record of increasing shareholder value and price. Absolutely love the long term growth and prospects for this company, even as it captures more market share every year. In saying that I will be adding to this sometime in early 2021 as I do feel that it has some bumps in the road over the next two quarters as more and more elective surgeries (which they specialize in) are being rescheduled due to the second round of lockdowns in Canada and the U.S. The price has run up and not taken into account these elective surgeries being rescheduled, so it should be corrected. The price will reflect this short term problem, but fundamentals of this company and it’s balance sheet are awesome. It is because of this I feel there is going to be a great entry point in the short term, and once Covid is more controlled the sky's the limit for this company. Keep a close eye on this one as a great entry point will arise in the near term and once you buy and hold, you will not regret it!
  • s
    Maintains Morgan Stanley Overweight USD 272 » USD 265 2021-01-28
    Target Raised by Deutsche Bank Buy USD 228 » USD 25
    Target Raised by Raymond James Financial Outperform USD 240 » USD 255
    Target Lowered by Credit Suisse Outperform » Outperform USD 278 » USD 273
  • Y
    Yahoo Finance Insights
    Stryker is up 4.97% to 237.81
  • s
    Reiterated by BTIG Research Buy USD 234 » USD 252
  • S
  • S
    Shanhawk Advisors
    let's go up 300 soon
  • R
    I first began buying SYK back in 2003 on the advice of an orthopedist friend of mine. I believe there's was one split in shares in 2004. Been purchasing ever since. Some of my shares I purchased in low - mid $30 range. Have been purchasing since. Today own close to 16,000 shares. Have sold shares infrequently over the last 15 years. Has been my best investment.
  • B
    When a company loses as much in market cap as the company they are acquiring, then you know that the street has overreacted. It is not as if the new business they are buying has $0. Go look at Abbv, BMY - both received similar treatment and people who bought those stocks after the haircut are up very nicely. For those saying that SYK overpaid, WMGI has been trading at similar levels in the past - the company being acquired is not just going to agree to the current share price. Also, none of us management - they might see a lot of different things - synergy, fending off competition, new areas of growth etc. Medical field is so daunting - you just don't create a gizmo and start selling it - there is a huge barrier to entry due to all the certifications etc. I have enjoyed very nice growth in SYK over the years - will double down - every time, I have seen this 10% down moves, the stock has recovered - just go look at the 5 year chart.
  • M
    Stryker is a stealthy frothy growth stock...kudos to management!
  • R
    I said a major announcement was coming last month (check my history), No announcements, however, their website has quietly changed. Notice anyone missing from the management team photos?
  • B
    What is happening with SYK. 3 investment houses downgraded SYK namely, Goldman Sachs, Citi and Morgan Stanley. Should I sell?
  • K
    I bought the dip, anyone else? This company simply buys and conquers the market.
  • J
    Who should SYK acquire next?
  • c
    I think investors are forgetting that orthopedic implants only make up about 1/3rd of Stryker’s business. Stryker also sells beds and acute patient care items that are in very high demand right now.
  • t
    I’ve owned this since 1990. Unfortunately, my initial investment was 1500 shares

    This is a great company

    Buy and hold
  • S
    I bought in too. The acquisition immediately completes Stryker's sports medicine offering plus gives them an even stronger foothold in Europe, and everything they buy works out. Brilliant company, consistent double digit growth, and a very reasonable PE. And Wright is no slouch...their growth rate was very impressive and warranted the high buyout price. It may not be glamorous, but even if the market corrects at some point, SYK will be at $250 in 2 years. And if you sell a few calls along the way after good runs, you can lock in a few more % points.
  • n
    Stryker buying Wright medical group. This might be the reason for the drop in share price.
  • B
    Once the coronavirus crisis is over, people will go back to getting the orthopedic surgery that they've been putting on hold the past few weeks. Stock has come down to a very attractive buying area and should rebound quickly once the coast is clear(within a few weeks imo)